144 related articles for article (PubMed ID: 2593768)
1. Distribution and molecular forms of glucagon-like peptide in the dog.
Suda K; Takahashi H; Fukase N; Manaka H; Tominaga M; Sasaki H
Life Sci; 1989; 45(19):1793-8. PubMed ID: 2593768
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide-1 (GLP-1) molecular forms in human pancreatic endocrine tumors resemble those in intestine rather than pancreas.
Tateishi K; Shima K; Funakoshi A; Yasunami Y; Iwamoto N; Matsuoka Y
Diabetes Res Clin Pract; 1994 Aug; 25(1):43-9. PubMed ID: 7835211
[TBL] [Abstract][Full Text] [Related]
3. Oxyntomodulin and glicentin: brain-gut peptides in the rat.
Blache P; Kervran A; Bataille D
Endocrinology; 1988 Dec; 123(6):2782-7. PubMed ID: 3197645
[TBL] [Abstract][Full Text] [Related]
4. Identification of amidated forms of GLP-1 in rat tissues using a highly sensitive radioimmunoassay.
van Delft J; Uttenthal LO; Hermida OG; Fontela T; Ghiglione M
Regul Pept; 1997 Jun; 70(2-3):191-8. PubMed ID: 9272633
[TBL] [Abstract][Full Text] [Related]
5. Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas.
Uttenthal LO; Ghiglione M; George SK; Bishop AE; Polak JM; Bloom SR
J Clin Endocrinol Metab; 1985 Sep; 61(3):472-9. PubMed ID: 2991321
[TBL] [Abstract][Full Text] [Related]
6. Identification and localization of glucagon-like peptide-1 and its receptor in rat brain.
Shimizu I; Hirota M; Ohboshi C; Shima K
Endocrinology; 1987 Sep; 121(3):1076-82. PubMed ID: 3040376
[TBL] [Abstract][Full Text] [Related]
7. Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans.
Orskov C; Rabenhøj L; Wettergren A; Kofod H; Holst JJ
Diabetes; 1994 Apr; 43(4):535-9. PubMed ID: 8138058
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactive glucagons purified from dog pancreas, stomach and ileum.
Shinomura Y; Eng J; Yalow RS
Regul Pept; 1988 Dec; 23(3):299-308. PubMed ID: 3238052
[TBL] [Abstract][Full Text] [Related]
9. Developmental patterns of glucagon-like peptide-1-(7-36) amide and peptide-YY in rat pancreas and gut.
Kreymann B; Ghatei MA; Domin J; Kanse S; Bloom SR
Endocrinology; 1991 Aug; 129(2):1001-5. PubMed ID: 1677327
[TBL] [Abstract][Full Text] [Related]
10. Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas.
Ghatei MA; Uttenthal LO; Bryant MG; Christofides ND; Moody AJ; Bloom SR
Endocrinology; 1983 Mar; 112(3):917-23. PubMed ID: 6822217
[TBL] [Abstract][Full Text] [Related]
11. Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat.
Kervran A; Blache P; Bataille D
Endocrinology; 1987 Aug; 121(2):704-13. PubMed ID: 3595539
[TBL] [Abstract][Full Text] [Related]
12. Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas.
Mojsov S; Kopczynski MG; Habener JF
J Biol Chem; 1990 May; 265(14):8001-8. PubMed ID: 1692320
[TBL] [Abstract][Full Text] [Related]
13. Presence of glucagon-(1-21)-Like immunoreactive substance in the dog small intestinal mucosa.
Itoh H; Namba M; Watanabe N; Ohara T; Matsuyama T; Komatsu R; Shinomura Y; Kono N; Tarui S
Biochem Biophys Res Commun; 1989 Dec; 165(3):1010-7. PubMed ID: 2610678
[TBL] [Abstract][Full Text] [Related]
14. Identification of glucagon-like peptide-1(7-36) amide in rat brain.
Yoshimoto S; Hirota M; Ohboshi C; Shima K
Ann Clin Biochem; 1989 Mar; 26 ( Pt 2)():169-71. PubMed ID: 2729860
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic and intestinal processing of proglucagon in man.
Orskov C; Holst JJ; Poulsen SS; Kirkegaard P
Diabetologia; 1987 Nov; 30(11):874-81. PubMed ID: 3446554
[TBL] [Abstract][Full Text] [Related]
16. Characterization of glucagon-like peptide-1-(7-36)amide in the hypothalamus.
Kreymann B; Ghatei MA; Burnet P; Williams G; Kanse S; Diani AR; Bloom SR
Brain Res; 1989 Nov; 502(2):325-31. PubMed ID: 2819470
[TBL] [Abstract][Full Text] [Related]
17. Release of glucagon-like peptide 1 immunoreactivity from the perfused rat pancreas.
Shima K; Hirota M; Ohboshi C; Sato M; Nishino T
Acta Endocrinol (Copenh); 1987 Apr; 114(4):531-6. PubMed ID: 3577586
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor.
Knudsen LB; Pridal L
Eur J Pharmacol; 1996 Dec; 318(2-3):429-35. PubMed ID: 9016935
[TBL] [Abstract][Full Text] [Related]
19. Identification of glucagon in the gastrointestinal tract.
Sasaki H; Rubalcava B; Baetens D; Blazquez E; Srikant CB; Orci L; Unger RH
J Clin Invest; 1975 Jul; 56(1):135-45. PubMed ID: 237936
[TBL] [Abstract][Full Text] [Related]
20. Comparison of sandwich enzyme-linked immunoadsorbent assay and radioimmunoassay for determination of exogenous glucagon-like peptide-1(7-36)amide in plasma.
Pridal L; Ingwersen SH; Larsen FS; Holst JJ; Adelhorst K; Kirk O
J Pharm Biomed Anal; 1995 Jun; 13(7):841-50. PubMed ID: 8562607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
